Research
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial
Hany Siha, Debraj Das, Yuling Fu, Yinggan Zheng, Cynthia M. Westerhout, Robert F. Storey, Stefan James, Lars Wallentin and Paul W. Armstrong
CMAJ July 10, 2012 184 (10) 1135-1142; DOI: https://doi.org/10.1503/cmaj.111683
Hany Siha
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MDDebraj Das
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
BMScYuling Fu
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MDYinggan Zheng
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MA MEdCynthia M. Westerhout
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
PhDRobert F. Storey
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MD DMStefan James
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MD PhDLars Wallentin
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MD PhDPaul W. Armstrong
From the University of Alberta (Siha, Das, Fu, Zheng, Westerhout, Armstrong), Edmonton, Alta.; the University of Sheffield (Storey), Sheffield, United Kingdom; and the Uppsala Clinical Research Center (James, Wallentin), Uppsala, Sweden
MD![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data supplements
Related Articles
- Mercuri, M., Natarajan, M. K., & Velianou, J. L. (2012). ST-elevation myocardial infarction: Is there time for Q waves?. CMAJ, 184(10), 1125-1126. Accessed August 16, 2024. https://doi.org/10.1503/cmaj.120624.
- (2012). Highlights. CMAJ, 184(10), 1119. Accessed August 16, 2024. Retrieved from http://www.cmaj.ca/content/184/10/1119.
In this issue
Article tools
Respond to this article
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial
Hany Siha, Debraj Das, Yuling Fu, Yinggan Zheng, Cynthia M. Westerhout, Robert F. Storey, Stefan James, Lars Wallentin, Paul W. Armstrong
CMAJ Jul 2012, 184 (10) 1135-1142; DOI: 10.1503/cmaj.111683
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial
Hany Siha, Debraj Das, Yuling Fu, Yinggan Zheng, Cynthia M. Westerhout, Robert F. Storey, Stefan James, Lars Wallentin, Paul W. Armstrong
CMAJ Jul 2012, 184 (10) 1135-1142; DOI: 10.1503/cmaj.111683
Jump to section
Related Articles
Cited By...
- Q Waves at Presentation in Patients With ST-Segment-Elevation Myocardial Infarction: An Underappreciated Marker of Risk
- Relationships Between Baseline Q Waves, Time From Symptom Onset, and Clinical Outcomes in ST-Segment-Elevation Myocardial Infarction Patients: Insights From the Vital Heart Response Registry
- Biochemical Validation of Patient-Reported Symptom Onset Time in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial
- Prognostic value of the ECG
- ST-elevation myocardial infarction: Is there time for Q waves?